Nutritional aspects and their influences on the pathophysiology of Alzheimer's disease
A systematic review
DOI:
https://doi.org/10.24220/2318-0897v23n1a2413Keywords:
Alzheimer disease, Antioxidants, Neurophysiology, Review literture as topicAbstract
The objective of this study was to conduct a review about the nutritional aspects and their influences on the pathophysiology of Alzheimer’s disease. The review describes the pathophysiology of Alzheimer’s disease, the generally indicated diets, and the nutritional factors that may aggravate the disease based on a literature review using the following keywords in English and Portuguese: “Alzheimer’s disease”, “physiopathology”, “nutritional aspects”, and “antioxidants”. A total of 100 articles were found, 48 in Lilacs and 52 in MedLine, but only 54 articles were selected for the review. The use of antioxidants as free radical scavengers is generally indicated in diets for Alzheimer’s patients. Studies also suggest that caffeine, vitamin B12, and folic acid have neuroprotective effects. Cohort studies found that a high intake of saturated fatty acids and obesity increase the risk of Alzheimer’s disease. People with Alzheimer’s disease should avoid diets high in carbohydrates and saturated fats, and prefer foods high in antioxidants.
Downloads
References
Harman D. A hypothesis on the pathogenesis of Alzheimer’s disease. Ann NY. 1996; 786(1):152-68.
Moriguti JC, Moriguti EKU, Ferriolli E, Cação JC, Iucif Junior N, Marchini JS. Involutary weight loss in elderly individuals: Assessment and treatment. Rev Paul Med. 2001; 119(2):72-7.
Gillete-Guyonnet S, Nourhashémi F, Andrieu S, Glisezinski I, Ousset PJ, Rivière D. Weight loss in Alzheimer disease. Am J Clin Nutr. 2000; 71(Suppl):637S-42S.
Machado J, Caram CLB, Frank AA, Soares EA, Laks J. Nutritional status in Alzheimer’s disease. Rev Assoc Med Bras. 2009; 55(2):188-91.
Forlenza OV. Tratamento farmacológico da doença de Alzheimer. Rev Psiq Clin. 2005; 32(3):137-48.
Dhitavat S, Ortiz D, Rogers E, Rivera E, Shea TB. Folate, vitamin E, and acetyl-l-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloidbeta. Brain Res. 2005; 1061(2):114-7.
Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci. 2004; 24(2):565-75.
Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s disease. Neurology. 1995; 45(8):1594-601.
Pappolla MA, Omar RA, Kim KS, Robakis NK. Immunohistochemical evidence of oxidative stress in Alzheimer’s disease. Am J Pathol. 1992; 140(3):621-8.
Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, Demaggio AJ. Transferrin and iron in normal, Alzheimer’s disease and Parkinson’s disease brain regions. J Neurochem. 1995; 65(2):710-24.
Bartzokis G, Tishler TA. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer´s and Huntington´s disease. Cell Mol Biol. 2000; 46:821-33.
Saavedra AT. Proponiendo biomarcadores para evaluar las alteraciones en la homeostasis cerebral de hierro y su relación con la fisiopatología de la Enfermedad de Alzheimer. Rev Chil Neuro-Psiquiatr. 2007; 45(1):29-41.
Bianchi MLP, Antunes LMG. Radicais livres e os principais antioxidantes da dieta. Rev Nutr. 1999; 12(2):123-30. doi: 10.1590/S1415-52731999000200001
Parihar MS, Hemnani T. Alzheimer’s disease pathogenesis and therapeutic interventions. J Clin Neur. 2004; 11(5):456-67.
Souza PHM, Souza Neto MH, Maia GA. Componentes funcionais nos alimentos. Boletim SBCTA. 2003; 37(2):127-35.
Moraes FP, Colla LM. Alimentos funcionais e nutracêuticos: definições, legislação e benefícios à saúde. Rev Elet Farm. 2006; 3(2):99-112.
Joseph JA, Shukitt-Hale NA, Denisova RL. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal transduction and cognitive behavioral deficits. J Neurosci. 1998; 18(19):8047-55.
Boni A, Pugliese C, Cláudio CC, Patin RV, Oliveira FLC. Vitaminas antioxidantes e prevenção da aterosclerose na infância. Rev Paul Pediatr. 2010; 28(4):373-80.
Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, Macfadyen J. Vitamins E and C in the prevention of cardiovascular disease in men: The Physicians’ Health Study II randomized controlled trial. JAMA. 2008; 300(18):2123-33.
Batlouni M. Hipótese oxidativa da aterosclerose e emprego dos antioxidantes na doença arterial coronária. Arq Bras Cardiol. 1997; 68(1):55-63.
Rique AB, Soares EA, Meirelles CM. Nutrição e exercício na prevenção e controle das doenças cardiovasculares. Rev Bras Med Esporte. 2002; 8(6):244-54.
Philippi ST. Pirâmide dos alimentos: fundamentos básicos da nutrição. São Paulo: Manole; 2008.
Manach C, Scalbert A, Morand C, Rémésy C, Jimenez, L. Polyphenols: Food sources and bioavailability. Am J Clin Nutr. 2004; 79(5):727-47.
Cerqueira FM, Medeiros MHG, Augusto O. Antioxidantes dietéticos: controvérsias e perspectivas.Quim Nova. 2007; 30(2):441-9.
Sun AY, Simonyi, A, Sun GY. The “French Paradox” and beyond: Neuroprotective effects of polyphenols. Free Radical Biol Med. 2002; 32(4):314-8.
Lee KW, Lee HJ, Surh YJ, Lee CY. Vitamin C and cancer chemoprevention: Reappraisal. Am J Clin Nutr. 2003; 78(6):1074-8.
Dreosti IE. Antioxidant polyphenols in tea, cocoa, and wine. Nutrition. 2000; 16(7-8):692-4.
Ho L, Chen LH, Wang J, Zhao W, Talcott ST, Ono K, et al. Heterogeneity in red wine polyphenolic contents differentially influences Alzheirmer’s disease-type neuropathology and cognitive deterioration. J Alzheimers Dis. 2009; 16(1):59-72.
Ribeiro MEM, Manfroi V. Vinho e saúde: uma visão química. RBVE. 2010; 2(2):91-103.
Lindsay J, Lauryn D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer’s disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002; 156(5):445-53.
Maia L, Mendonça A. Does caffeine intake protect from Alzheimer’s disease? Eur J Neurol. 2002; 9(4):377-82.
Dall’lgna OP, Porciúncula LO, Souza DO, Cunha RA, Lara DR. Neuroprotection by caffeine and Adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Br J Pharmacol. 2003; 138(7):1207-9.
Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, et al. Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience. 2006; 142(4):941.
Zandi PP, Anthony JC, KhachaTurian AS, Stone SV, Gustafson D, Tschanz JT, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Arch Neurol. 2004; 61(1):82-8.
Cho ES, Jang YJ, Hwang MK, Lee KW, Lee HJ. Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals. Mutat Res. 2009; 661(1-2):18-24.
Alves RC, Casal S, Oliveira B. Benefícios do café na saúde: mito ou realidade? Quím Nova. 2009; 32(8):2169-80.
Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006; 5(11):949-60.
Futterleib A, Cherubini X. Importância da vitamina B12 na avaliação clinicado paciente idoso. Scientia Medica. 2005; 15(1):74-8.
Olivo LP, Stella HJ, Malheiros SVP, Breda-Stella M. Envolvimento da Vitamina B12, da homocisteína e do folato no desenvolvimento demência. Rev Multidiscip Saúde. 2009; 1(2):51-64.
Van Der Beek EM, Kamphuis PJGH. The potential role of nutritional components in the management of Alzheimer’s Disease. Eur J Pharmacol. 2008; 585(1):197-207.
Ailhaud G, Guesnet P. Fatty acid composition of fats is an early determinant of childhood obesity: A short review and an opinion. Obes Rev. 2004; 5(1):21-6.
Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997; 42(5):776-82.
Luchsinger JA, Tang MX, Shea S, Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol. 2002; 59(8):1258-63.
Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol. 2003; 60(2):194-200.
Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003; 60(7):940-6.
Ortega RM. Importance of functional foods in the Mediterranean diet. Public Health Nutr. 2006; 9(8A):1136-40.
Mancini M, Stamler J. Diet for preventing cardiovascular diseases: Light from Ancel Keys, distinguished centenarian scientist. Nutr Metab Cardiovasc Dis. 2004; 14(1):52-7.
Seneff S, Wainwright G, Mascitelli L. Nutrition and Alzheimer’s disease: The detrimental role of a high carbohydrate diet. Eur J Int Med. 2011; 22(2):134-40.
Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer’s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U.S.A. 2001; 98(10):5856-61.
Refolo LM, Malester B, Lafrancois J, Bryant-Thomas T, Wang R, Tint GS, et al. Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis. 2000; 7(4):321-31.
Refolo LM, Pappolla MA, Lafrancois J, Malester B, Schmidt SD, Thomas-Bryant T, et al. A cholesterol lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer’s disease. Neurobiol Dis. 2001; 8(5):890-9.
Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol. 2004; 167(5):953-60.
Grant WB. Dietary links to Alzheimer’s disease. Alzheimer’s Disease Rev. 1997; 2:42-55.
Henderson ST. High carbohydrate diets and Alzheimer’s disease. Med Hypoth. 2004; 62(5):689-700.
Engelhart MJ, Geerlings MI, Ruitenberg A, Swieten JC van, Hofman A, Witteman JC, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002; 287(24):3223-9.
